Published date: 19 February 2021
This notice was replaced on 23 August 2022
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 23 August 2022)
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Influenza vaccines - 33651660
Location of contract
RG1 7EB
Value of contract
£0
Procurement reference
CF-0095000D0O000000rwimUAA1
Published date
19 February 2021
Closing date
31 May 2012
Closing time
12am
Contract start date
31 May 2012
Contract end date
31 May 2022
Contract type
Supply contract
Procedure type
Competitive procedure with negotiation (above threshold)
Anyone may ask to participate, but only those who are pre-selected will be invited to submit initial tenders and to negotiate.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
12 month extension to the Advanced Purchase Agreement for Pandemic Influenza Specific Vaccine contract brought about under Regulation 72c due to the Covid-19 virus impact.
More information
Links
-
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kGV7/cvpuwcXu8CRFBdA0cTRNkT0FvsshKomIN.PqT.L1Xyo
- 201214 Seqirus Contract Variation Agreement Final v1 - Redacted
Award information
Awarded date
13 November 2020
Contract start date
31 May 2012
Contract end date
31 May 2022
Total value of contract
£0
This contract was awarded to 1 supplier.
Seqirus UK Limited
Address
29 Market Street SL6 8AA
Reference
None
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Gill Lloyd-Jones
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice